KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Invested Capital (2016 - 2025)

Teladoc Health (TDOC) has disclosed Invested Capital for 13 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 32.13% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, down 32.13% year-over-year, with the annual reading at $1.4 billion for FY2025, 32.13% down from the prior year.
  • Invested Capital hit $1.4 billion in Q4 2025 for Teladoc Health, roughly flat from $1.4 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $16.0 billion in Q4 2021 to a low of $1.4 billion in Q4 2025.
  • Historically, Invested Capital has averaged $5.6 billion across 5 years, with a median of $2.3 billion in 2023.
  • Biggest five-year swings in Invested Capital: soared 1482.67% in 2021 and later crashed 85.62% in 2022.
  • Year by year, Invested Capital stood at $16.0 billion in 2021, then plummeted by 85.62% to $2.3 billion in 2022, then grew by 0.79% to $2.3 billion in 2023, then decreased by 12.22% to $2.0 billion in 2024, then crashed by 32.13% to $1.4 billion in 2025.
  • Business Quant data shows Invested Capital for TDOC at $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.